Award NoticePosted Dec 2, 2024

Q--Childhood Cancer Data Initiative (CCDI)

National Institutes of Health · NIH NCI

Stage
Awarded
NAICS
541380
Value
$35.0M
Solicitation
75N91023R00042
Set-aside
None stated
PSC
Q301
Place
Not stated
Contact
FELENT, ERIN A (erin.felent@nih.gov)

No listed company matched (Materiality N/A)

Loading your pipeline and notes…
CSV Email

Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.

Where this opportunity stands

Every notice posted under solicitation 75N91023R00042 in this department, oldest first.

Early notice
  • Apr 8, 2024
    Pre-solicitation
    Open
Solicitation
  • May 1, 2024
    Solicitation
    Open
  • May 15, 2024
    Solicitation
    Open
Award
  • Dec 2, 2024 · this notice
    Award Notice
    AZENTA US INC · $35.0M

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

  • Note the winner and the end of the period of performance for the recompete.
  • Follow the agency to see the next notice for this work.

What the notice says

A new award to support the research molecular characterization goals of the Childhood Cancer Data Initiative (CCDI) to improve diagnosis and treatment for childhood and adolescent and young adult (AYA) cancers.

Who won similar work

6 award notices on SAM.gov in the last 24 months. Matched by: Same office (NIH NCI), same NAICS 541380.

WinnerAwardsValueLast
INFINITY BIOLOGIX LLC1– + 1 sharedJan 8, 2025
NEW YORK GENOME CENTER, INC.1– + 1 sharedJan 10, 2025
SEQMATIC, LLC1– + 1 sharedJan 8, 2025
UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL ADMINISTRATIVE OFFICE BUILDING, SUITE 2200 104 AIRPORT DRIVE, SUITE 2200, CB 1350 Chapel Hill NC 27599 USA1– + 1 sharedJan 10, 2025
UNIVERSITY OF SOUTHERN CALIFORNIA 3720 S FLOWER STREET FL 3 Los Angeles CA 90089 USA1– + 1 sharedJan 10, 2025
Washington University, The CAMPUS BOX 1054 ONE BROOKINGS DRIVE SAINT LOUIS MO 63130 USA1– + 1 sharedJan 8, 2025

Value counts new single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling (same contract, or the same office, day and amount); that ceiling is not one company's win, so it is not added in. Contract modifications are not new awards and are not added in either. Revenue next to a ticker is the company's revenue over the latest 12 months in its SEC filings.

Latest awards

Competitive landscape

For the 6 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

  • 0 of these past winners lobbied Natl Institutes of Health (NIH) since 2024 (0 filings)
  • 0 of their lobbyists list a past Natl Institutes of Health (NIH) job
  • No corporate PAC money from them to the overseeing committees since 2024
  • 0 foreign-agent (FARA) registrations
See who and the source records with Pro

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

  • 0 bills named on the past winners' lobbying filings
  • 0 rules from the department in the last 12 months
  • 0 executive orders naming the agency in the last 12 months
See who and the source records with Pro

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.

  • 0 of the past winners are listed companies
  • 0 insider buys and 0 insider sells at them in the last 90 days
See who and the source records with Pro

Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.

Companies are matched to tickers by exact name, including the subsidiaries a company lists in its SEC filings. A company we could not match shows no market rows; that is a miss, not a finding.